Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020

SELL
$32.37 - $59.36 $474,414 - $869,980
-14,656 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$32.22 - $50.07 $339,985 - $528,338
-10,552 Reduced 41.86%
14,656 $704,000
Q3 2019

Nov 14, 2019

SELL
$33.82 - $48.17 $1.68 Million - $2.4 Million
-49,792 Reduced 66.39%
25,208 $853,000
Q2 2019

Aug 12, 2019

BUY
$35.42 - $45.0 $2.66 Million - $3.38 Million
75,000 New
75,000 $3.38 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.28B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Atika Capital Management LLC Portfolio

Follow Atika Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.